These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1015349)

  • 1. [Clinical problems of alcoholic cirrhosis. IV. Various phases of liver cirrhosis and reliability limits of laboratory analyses performed in such phases].
    Knezević S; Wulff HR; Knezević S; Madarić M; Falisevac V
    Acta Med Iugosl; 1976; 30(5):483-96. PubMed ID: 1015349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical problems of alcoholic cirrhosis. III. Laboratory findings, reliability limits and sensitivity in patients with liver cirrhosis in various phases of the disease].
    Knezević S; Wulfe HR; Kneźevic S; Madarić M; Falisevac V
    Acta Med Iugosl; 1976; 30(5):469-81. PubMed ID: 1015348
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute alcoholic hepatitis (fatty liver hepatitis)].
    Sohnack H
    Wien Med Wochenschr; 1972 Jul; 122(30):460-4. PubMed ID: 5065650
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discriminant diagnostic power of liver function tests in hepatic cirrhosis.
    Serra MA; Rodrigo JM; Guix J; Montes F; Wassel A; Aparisi L; Olmo JA; Bixquert M
    Acta Med Port; 1981; 3(1):3-10. PubMed ID: 7304266
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and biopsy studies on the course of fatty liver hepatitis].
    Denk H; Leodolter I; Schnack H; Thaler H
    Wien Klin Wochenschr; 1970 Feb; 82(6):98-101. PubMed ID: 5513205
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical diagnosis of alcoholic fatty liver.
    Devenyi P; Rutherdale J; Sereny G; Olin JS
    Am J Gastroenterol; 1970 Dec; 54(6):597-602. PubMed ID: 5504217
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma tyrosine level in liver diseases].
    Selmair H; Langness U; Zimmermann J; Herborn U
    Med Klin; 1971 Jun; 66(30):1049-52. PubMed ID: 5569262
    [No Abstract]   [Full Text] [Related]  

  • 9. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H; Björnsson E; Simrén M; Aldenborg F; Almer S; Olsson R
    Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical problem of alcoholic cirrhosis. II. Attempt at evaluation of individual laboratory findings in patients with liver cirrhosis in various stages of the disease].
    Knezević S; Kallai L; Falisevac V; Hadzic N; Pichler E; Spicer F
    Acta Med Iugosl; 1975; 29(2):135-55. PubMed ID: 1136846
    [No Abstract]   [Full Text] [Related]  

  • 11. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA; Braconier JH; Eriksson O
    Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Short-term prognosis of the patient with alcoholic cirrhosis by the use of discriminant function analysis].
    Conti F; Mandelli V; Natangelo R; Cattani F; Tamassia V
    Minerva Med; 1972 Mar; 63(17):994-9. PubMed ID: 5016060
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged observations on the liver function tests in infectious hepatitis.
    Strickland GT; Castell DO; Kronmal RA
    Am J Gastroenterol; 1971 Mar; 55(3):257-64. PubMed ID: 5578089
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laboratory studies in hyperemesis gravidarum. (I)].
    Neumayer E; Stark KH
    Zentralbl Gynakol; 1968 Oct; 90(42):1417-23. PubMed ID: 5703630
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
    Flisiak R; Pytel-Krolczuk B; Prokopowicz D
    Cytokine; 2000 Jun; 12(6):677-81. PubMed ID: 10843744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver clearance of bromosulphalein (BSF) in cirrhosis].
    Rodés J; Bordas JM; Bruguera M; Terés J
    Rev Clin Esp; 1968 Nov; 111(3):303-14. PubMed ID: 5736056
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of glutamic pyruvic transaminase isoenzymes in human serum.
    Orfanos AP; Gabrieli ER; Pragay DA
    Res Commun Chem Pathol Pharmacol; 1970 Mar; 1(2):266-77. PubMed ID: 5524322
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombocytopenia and liver cirrhosis].
    Frick W
    Schweiz Med Wochenschr; 1967 Apr; 97(13):407-13. PubMed ID: 4174227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.